Structural and functional specificity of H3K36 methylation

UTF Lam, BKY Tan, JJX Poh, ES Chen - Epigenetics & Chromatin, 2022 - Springer
The methylation of histone H3 at lysine 36 (H3K36me) is essential for maintaining genomic
stability. Indeed, this methylation mark is essential for proper transcription, recombination …

The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors

I Topchu, RP Pangeni, I Bychkov, SA Miller… - Cellular and Molecular …, 2022 - Springer
Abstract NSD1, NSD2, and NSD3 constitute the nuclear receptor-binding SET Domain
(NSD) family of histone 3 lysine 36 (H3K36) methyltransferases. These structurally similar …

The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate

Y Li, P Trojer, CF Xu, P Cheung, A Kuo… - Journal of Biological …, 2009 - ASBMB
The NSD (nuclear receptor SET domain-containing) family of histone lysine
methyltransferases is a critical participant in chromatin integrity as evidenced by the number …

The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation

Q Qiao, Y Li, Z Chen, M Wang, D Reinberg… - Journal of Biological …, 2011 - ASBMB
The Sotos syndrome gene product, NSD1, is a SET domain histone methyltransferase that
primarily dimethylates nucleosomal histone H3 lysine 36 (H3K36). To date, the intrinsic …

The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors

HR Hudlebusch, E Santoni-Rugiu, R Simon… - Clinical cancer …, 2011 - AACR
Abstract Purpose: Multiple myeloma SET (Suppressor of variegation, Enhancer of zeste, and
Trithorax) domain (MMSET) is a histone lysine methyltransferase deregulated in a subgroup …

NSD2 is a conserved driver of metastatic prostate cancer progression

A Aytes, A Giacobbe, A Mitrofanova, K Ruggero… - Nature …, 2018 - nature.com
Deciphering cell-intrinsic mechanisms of metastasis progression in vivo is essential to
identify novel therapeutic approaches. Here we elucidate cell-intrinsic drivers of metastatic …

[HTML][HTML] The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

Y Yang, M Zhang, Y Wang - Journal of the National Cancer Center, 2022 - Elsevier
Histone modifications are key factors in chromatin packaging, and are responsible for gene
regulation during cell fate determination and development. Abnormal alterations in histone …

Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer

L Zhao, Q Li, ZJ Huang, MX Sun, J Lu, X Zhang… - Cell Death & …, 2021 - nature.com
Colorectal cancer (CRC) is the second common cause of cancer-related human mortalities.
Dysregulation of histone 3 (H3) methylation could lead to transcriptional activation of …

The lncRNA SLNCR recruits the androgen receptor to EGR1-bound genes in melanoma and inhibits expression of tumor suppressor p21

K Schmidt, JS Carroll, E Yee, DD Thomas… - Cell reports, 2019 - cell.com
Melanoma is the deadliest form of skin cancer, affecting men more frequently and severely
than women. Although recent studies suggest that differences in activity of the androgen …

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

A Parolia, S Eyunni, BK Verma, E Young, Y Liu, L Liu… - Nature Genetics, 2024 - nature.com
Androgen receptor (AR) is a ligand-responsive transcription factor that drives terminal
differentiation of the prostatic luminal epithelia. By contrast, in tumors originating from these …